Alzecure Q3 2024: Business development on the agenda - Redeye
Redeye returns with an update following Alzecure's Q3 report. In relation to this update, we make some adjustments to our deal and pipeline assumptions.
ANNONS
Redeye returns with an update following Alzecure's Q3 report. In relation to this update, we make some adjustments to our deal and pipeline assumptions.